腫瘤科
陳德章 教授
副校長（校友／社區聯繫及大學拓展） 李樹芬醫學基金腫瘤學講座教授
腫瘤學系，香港中文大學
研究範疇 <只提供英文版本>
- Clinical and translational research in Nasopharyngeal Carcinoma
履歷概要 <只提供英文版本>
Professor Anthony Chan is Pro-Vice-Chancellor / Vice-President, Li Shu Fan Medical Foundation Professor of Clinical Oncology, Director of The Chinese University of Hong Kong Clinical Trial Centre, Director of the Hong Kong Cancer Institute, Director of the Sir YK Pao Centre for Cancer, Associate Director of State Key Laboratory of Translational Oncology, and Master of Wu Yee Sun College at The Chinese University of Hong Kong.
Professor Chan conducted pivotal studies setting new treatment standards in multimodality approaches in nasopharynx cancer, developed the clinical applications of the biomarker EBV DNA and pioneered immunotherapeutic and targeted therapeutics in this disease. He has published extensively in international journals, and also delivered hundreds of international lectures. He has published reviews in Lancet and Nature Reviews Clinical Oncology as well as European Society for Medical Oncology (ESMO) treatment guidelines for Nasopharyngeal Cancer. He has served on the Editorial Board of Journal of Clinical Oncology and has been Associate Editor of Annals of Oncology since 2014. Professor Chan was honoured with the 2023 ESMO Lifetime Achievement Award in recognition for his leadership and outstanding research in nasopharyngeal cancer.